Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Paper
  • Published:

Induction of apoptosis and G2/M arrest by infection with replication-deficient adenovirus at high multiplicity of infection

Gene Therapy volume 6, pages 1054–1063 (1999)Cite this article

Abstract

Replication-deficient adenoviruses are among the most widely used vectors in gene therapy and are also becoming increasingly popular as analytical tools in basic research. However, significant toxicity of these vectors in vivo has been reported. Here, we show that in an in vitro setting, first generation adenoviruses lead to growth retardation, prolongation of the G2/M phase and induction of apoptosis if applied at a high multiplicity of infection (MOI). These findings were obtained in p53-deficient hepatocytes, derived from knock-out mice (A2 cells) and in several tumor cell lines containing wild-type (wt) or mutant p53. Apoptosis induction was correlated with increased levels of p53 and bax proteins and it was stronger in cells containing wt p53 as compared with cells lacking functional p53. Apoptosis was highly dependent on the MOI used with marked effects starting at an MOI twice as high as needed for 100% gene transfer. Expression of the adenoviral E4 ORF6 gene as well as adenoviral replication were detected in all cell lines infected with first generation adenovirus. Apoptosis could be considerably reduced but not abrogated by UV inactivation of adenovirus, which indicates proapoptotic effects caused by the infection event as well as by residual adenoviral gene expression or adenoviral replication. First generation adenoviruses apparently display proapoptotic activity if used at higher MOIs, which may be of relevance when these vectors are used as analytical or gene therapeutic tools.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9
Figure 10
Figure 11

Similar content being viewed by others

References

  1. Amalfitano A et al. Production and characterization of improved adenovirus vectors with the E1, E2b, and E3 genes deleted J Virol 1998 72: 926–933

    CAS  PubMed  PubMed Central  Google Scholar 

  2. Nevins JR . Mechanism of activation of early viral transcription by the adenovirus E1A gene product Cell 1981 26: 213–220

    CAS  PubMed  Google Scholar 

  3. Yang Y et al. Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis Nat Genet 1994 7: 362–369

    CAS  PubMed  Google Scholar 

  4. Lieber A, He CY, Kirillova I, Kay MA . Recombinant adenoviruses with large deletions generated by CRE-mediated excision exhibit different biological properties compared with first-generation vectors in vitro and in vivo J Virol 1996 70: 8944–8960

    CAS  PubMed  PubMed Central  Google Scholar 

  5. Li Q et al. Assessment of recombinant adenoviral vectors for hepatic gene therapy Hum Gene Ther 1993 4: 403–409

    CAS  PubMed  Google Scholar 

  6. Lieber A et al. The role of Kupffer cell activation and viral gene expression in early liver toxicity after infusion of recombinant adenovirus vectors J Virol 1997 71: 8798–8807

    CAS  PubMed  PubMed Central  Google Scholar 

  7. Nielsen LL et al. Recombinant E1-deleted adenovirus-mediated gene therapy for cancer: efficacy studies with p53 tumor suppressor gene and liver histology in tumor xenogaft models Hum Gene Ther 1998 9: 681–694

    CAS  PubMed  Google Scholar 

  8. Teodoro JG, Branton PE . Regulation of apoptosis by viral gene products J Virol 1997 71: 1739–1746

    CAS  PubMed  PubMed Central  Google Scholar 

  9. Heyman RA et al. Thymidine kinase obliteration: creation of transgenic mice with controlled immune deficiency Proc Natl Acad Sci USA 1989 86: 2698–2702

    CAS  PubMed  Google Scholar 

  10. Macri P, Gordon JW . Delayed morbidity and mortality of albumin/SV40 T-antigen transgenic mice after insertion of an alpha-fetoprotein/herpes virus thymidine kinase transgene and treatment with ganciclovir Hum Gene Ther 1994 5: 175–182

    CAS  PubMed  Google Scholar 

  11. Moolten FL . Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy Cancer Res 1986 46: 5276–5281

    CAS  PubMed  Google Scholar 

  12. Chen X, Ko LJ, Jayaraman L, Prives C . p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells Genes Dev 1996 10: 2438–2451

    CAS  PubMed  Google Scholar 

  13. Bressac B et al. Abnormal structure and expression of p53 gene in hepatocellular carcinoma Proc Natl Acad Sci USA 1990 87: 1973–1976

    CAS  PubMed  Google Scholar 

  14. Hosono S et al. Molecular analysis of the p53 alleles in primary hepatocellular carcinomas and cell lines Oncogene 1991 6: 237–243

    CAS  PubMed  Google Scholar 

  15. Noble JR, Willetts KE, Mercer WE, Reddel RR . Effects of exogenous wild-type p53 on a human lung carcinoma cell line with endogenous wild-type p53 Exp Cell Res 1992 203: 297–304

    CAS  PubMed  Google Scholar 

  16. Löser P, Jennings GS, Strauss M, Sandig V . Reactivation of the previously silenced cytomegalovirus major immediate–early promoter in the mouse liver: involvement of NFκB J Virol 1998 72: 180–190

    PubMed  PubMed Central  Google Scholar 

  17. Allen RT, Cluck MW, Agrawal DK . Mechanisms controling cellular suicide: role of Bcl-2 and caspases Cell Mol Life Sci 1998 54: 427–445

    CAS  PubMed  Google Scholar 

  18. Clesham GJ et al. High adenoviral loads stimulate NF kappaB-dependent gene expression in human vascular smooth muscle cells Gene Therapy 1998 5: 174–180

    CAS  PubMed  Google Scholar 

  19. Lin KI et al. Thiol agents and Bcl-2 identify an alphavirus-induced apoptotic pathway that requires activation of the transcription factor NF-kappa B J Cell Biol 1995 131: 1149–1161

    CAS  PubMed  Google Scholar 

  20. Marianneau P et al. Dengue virus replication in human hepatoma cells activates NF-kappaB which in turn induces apoptotic cell death J Virol 1997 71: 3244–3249

    CAS  PubMed  PubMed Central  Google Scholar 

  21. Baeuerle PA, Baltimore D . NF-kappa B: ten years after Cell 1996 87: 13–20

    CAS  PubMed  Google Scholar 

  22. Bruder JT, Kovesdi I . Adenovirus infection stimulates the Raf/MAPK signaling pathway and induces interleukin-8 expression J Virol 1997 71: 398–404

    CAS  PubMed  PubMed Central  Google Scholar 

  23. Downward J . Ras signaling and apoptosis Curr Opin Genet Dev 1998 8: 49–54

    CAS  PubMed  Google Scholar 

  24. Tollefson AE et al. The adenovirus death protein (E3–116K) is required at very late stages of infection for efficient cell lysis and release of adenovirus from infected cells J Virol 1996 70: 2296–2306

    CAS  PubMed  PubMed Central  Google Scholar 

  25. Marcellus RC et al. Adenovirus type 5 early region 4 is responsible for E1A-induced p53-independent apoptosis J Virol 1996 70: 6207–6215

    CAS  PubMed  PubMed Central  Google Scholar 

  26. Klessig DF, Brough DE, Cleghon V . Introduction, stable integration, and controlled expression of a chimeric adenovirus gene whose product is toxic to the recipient human cell Mol Cell Biol 1984 4: 1354–1362

    CAS  PubMed  PubMed Central  Google Scholar 

  27. Zhou H, O’Neal W, Morral N, Beaudet AL . Development of a complementing cell line and a system for construction of adenovirus vectors with E1 and E2a deleted J Virol 1996 70: 7030–7038

    CAS  PubMed  PubMed Central  Google Scholar 

  28. Spergel JM, Chen Kiang S . Interleukin 6 enhances a cellular activity that functionally substitutes for E1A protein in transactivation Proc Natl Acad Sci USA 1991 88: 6472–6476

    CAS  PubMed  Google Scholar 

  29. He J et al. Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2-phase of the cell cycle by inhibiting p34cdc2 activity J Virol 1995 69: 6705–6711

    CAS  PubMed  PubMed Central  Google Scholar 

  30. Jault FM et al. Cytomegalovirus infection induces high levels of cyclins, phosphorylated RB, and p53, leading to cell cycle arrest J Virol 1995 69: 6697–6704

    CAS  PubMed  PubMed Central  Google Scholar 

  31. Wersto RP et al. Recombinant, replication-defective adenovirus gene transfer vectors induce cell cycle dysregulation and inappropriate expression of cyclin proteins J Virol 1998 72: 9491–9502

    CAS  PubMed  PubMed Central  Google Scholar 

  32. Teramoto S et al. Effect of adenoviral vector infection on cell proliferation in cultured primary human airway epithelial cells Hum Gene Ther 1995 6: 1045–1053

    CAS  PubMed  Google Scholar 

  33. Donehower LA et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors Nature 1992 356: 215–221

    CAS  Google Scholar 

  34. Brand K et al. Liver-associated toxicity of the HSV-tk/GCV approach and adenoviral vectors Cancer Gene Ther 1997 4: 9–16

    CAS  PubMed  Google Scholar 

  35. Zhang WW et al. High-efficiency gene transfer and high-level expression of wild-type p53 in human lung cancer cells mediated by recombinant adenovirus Cancer Gene Ther 1993 1: 5–13

    Google Scholar 

  36. Stratford-Perricaudet LD, Makeh I, Perricaudet M, Briand P . Widespread long term gene transfer to mouse skeletal muscles and heart J Clin Invest 1992 90: 626–630

    CAS  PubMed  PubMed Central  Google Scholar 

  37. Dion LD, Fang J, Garver RI Jr . Supernatant rescue assay vs. polymerase chain reaction for detection of wild type adenovirus-contaminating recombinant adenovirus stocks J Virol Meth 1996 56: 99–107

    CAS  Google Scholar 

  38. Sandig V et al. HBV-derived promoters direct liver-specific expression of an adenovirally transduced LDL receptor gene Gene Therapy 1996 3: 1002–1009

    CAS  PubMed  Google Scholar 

  39. Hirt B . Selective extraction of polyoma DNA from infected mouse cell cultures J Mol Biol 1967 26: 365–369

    CAS  PubMed  Google Scholar 

  40. Cotten M et al. Psoralen treatment of adenovirus particles eliminates virus replication and transcription while maintaining the endosomolytic activity of the virus capsid Virology 1994 205: 254–261

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported in part by the Deutsche Forschungsgemeinschaft (DFG)-Sonderforschungsbereich 506: Onkotherapeutische Nukleinsäuren.

Author information

Authors and Affiliations

  1. Institut für Biologie, Humboldt-Universität Berlin, Berlin, Germany

    K Brand, A Poβling & M Strauss

  2. Fraunhofer Institut für Toxikologie und Aerosolforschung, Hannover, Germany

    R Klocke & D Paul

Authors
  1. K Brand
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R Klocke
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A Poβling
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D Paul
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M Strauss
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Brand, K., Klocke, R., Poβling, A. et al. Induction of apoptosis and G2/M arrest by infection with replication-deficient adenovirus at high multiplicity of infection. Gene Ther 6, 1054–1063 (1999). https://doi.org/10.1038/sj.gt.3300914

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3300914

Keywords

This article is cited by

Search

Advanced search

Quick links